LCM
JSPR icon

Landscape Capital Management’s Jasper Therapeutics JSPR Stock Holding History

Landscape Capital Management’s Portfolio JSPR Stock Details JSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-11,397
Closed -$335K – 804
2024
Q1 		$335K Sell
11,397
-67,536
-86% -$1.2M 0.03% 519
2023
Q4 		$623K Buy
+78,933
New +$530K 0.06% 344
2021
Q3 		– Sell
-8,489
Closed -$844K – 787
2021
Q2 		$844K Buy
+8,489
New +$844K 0.1% 210

Other funds holding JSPR

VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
QUSVM
Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Landscape Capital Management's JSPR Position: Q2 2024 in Review

Landscape Capital Management sold out of Jasper Therapeutics (JSPR) in Q2 2024, closing a stake of 11,397 shares — an estimated $335K sold.

Landscape Capital Management first reported a position in JSPR in Q2 2021 and held it in 3 quarters. The position peaked at $844K in Q2 2021. 69 funds tracked by Wall St. Rank hold JSPR as of Q2 2024.

  • Landscape Capital Management reported no remaining Jasper Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Landscape Capital Management sold 11,397 Jasper Therapeutics shares in Q2 2024, an estimated $335K.
  • Landscape Capital Management first reported a position in Jasper Therapeutics in Q2 2021 and held it in 3 quarters.
  • Landscape Capital Management's Jasper Therapeutics position peaked at $844K in Q2 2021.
  • 69 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q2 2024.

Based on Landscape Capital Management's 13F filing for Q2 2024, filed 12 Aug 2024.